The resignation of the head of the U.S. Food and Drug Administration (FDA) has contributed to growing concerns regarding leadership vacancies within the agency.
Kyle Diamantas, a lawyer, has been appointed as the acting leader of the FDA, taking on this role amidst worries about a hantavirus outbreak.
This transition in leadership comes at a crucial moment, as the FDA navigates public health challenges and seeks to maintain its regulatory responsibilities.